BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bordeaux Neurocampus - ECPv4.9.10//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bordeaux Neurocampus
X-ORIGINAL-URL:https://www.bordeaux-neurocampus.fr
X-WR-CALDESC:Évènements pour Bordeaux Neurocampus
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20230331T140000
DTEND;TZID=Europe/Paris:20230331T140000
DTSTAMP:20260408T185231
CREATED:20230131T083831Z
LAST-MODIFIED:20230301T104231Z
UID:154951-1680271200-1680271200@www.bordeaux-neurocampus.fr
SUMMARY:Seminar - Carla Nasca
DESCRIPTION:Venue: Centre Broca Nouvelle-Aquitaine \n\nCarla Nasca\nNew York University (NYU) School of Medicine\nDepartments of Psychiatry & Neuroscience\, New York \nInvited by Marie-Pierre Moisan (NutriNeuro) \nTitle\nExosomes and Mitochondrial Metabolism: Novel Epigenetic Mechanisms of Neuroplasticity in Stress and Psychiatric Disorders \nAbstract\nAt NYU School of Medicine\, Dr. Nasca lab is working on an innovative framework of epigenetic mechanisms of neuroplasticity in stress responses and psychiatric disorders with a new angle on mitochondrial metabolism. Key to this framework is the pivotal mitochondrial metabolite L-acetylcarnitine (LAC)\, which she discovered as a novel epigenetic modulator of hippocampal plasticity and a therapeutic target for clinical phenotypes of depression associated with childhood trauma.  Using the novel exosome technology\, her group further showed that modulating mitochondrial metabolism of LAC is predictive of changes in other important aspects of human physiology\, such as insulin resistance. We hope this new knowledge can ultimately lead to neurosciencebased personalized medicine strategies for stress-related diseases\, including depression. \nBiosketch\nDr. Nasca is Head of the laboratory of Epigenetics & System Neuroscience and Assistant Professor at NYU School of Medicine in New York in the Departments of Psychiatry and Neuroscience. She joined NYU after directing her own research group at Rockefeller University where she previously trained in Neuroscience with Bruce McEwen. She also received training in Translational Neuroscience. Dr. Nasca received numerous federal and foundation research grants\, including a R01 grant and the High Priority research grant from National Institute of Mental Health (NIMH) and the Falk Transformative Research Award. She also is a recipient of the Blavatnik Award for Innovative Research. \nKey publications\n*Nasca C\, Bigio B\, Zelli D\, Okamoto M\, Soya H\, Ni J\, Greengard P\, Neve R\, Lee F\, McEwen B (2017). Role of the astroglial glutamate exchanger xCT in ventral hippocampus in resilience to stress. Neuron 2:402-413 \nMcEwen BS\, Bowles N\, Gray JD\, Hill MN\, Hunter R\, Karatsoreos IN\, Nasca C (2015). Mechanisms of stress in the brain. Nature Neuroscience 10:1353-63 PMCID: PMC4933289 \n*Nasca C\, Menard C\, Hodes G\, Bigio B\, Pena C\, Lorsch Z\, Merad M\, Meaney MJ\, Nestler EJ\, McEwen BS\, Russo SJ (2019). Multidimensional Predictors of Susceptibility and Resilience to Social Defeat Stress. Biological Psychiatry 86:483-491 PMCID: PMC6730655 \n*Nasca C\, Dobbin J\, Bigio B\, Watson K\, Lee FS\, Murrough J\, McEwen B\, Rasgon N (2020). Insulin receptor substrate in brain-enriched exosomes in subjects with major depression: on the path of creation of biosignatures of central insulin resistance. Nature Molecular Psychiatry 26:5140-5149 PMCID: PMC7787430 \n
URL:https://www.bordeaux-neurocampus.fr/event/seminar-carla-nasca/
CATEGORIES:A la une,Pour les scientifiques,Séminaire Impromptu
END:VEVENT
END:VCALENDAR